Skip to main content
Caplight Logo









Allgenesis Biotherapeutics Inc.

Allgenesis Biotherapeutics Inc.

Private
TaipeiHealthcare & Life Scienceshttps://allgenesis.com

Company Overview

Allgenesis Biotherapeutics Inc. operates in Healthcare & Life Sciences and is based in Taipei. It was founded in 2014.

Allgenesis Biotherapeutics Inc. is a biopharmaceutical company that focuses on the research and development of novel ophthalmic medicines for the treatment of eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Allgenesis Biotherapeutics Inc. Comparables

Compare Allgenesis Biotherapeutics Inc. with similar companies based on industry and business-model similarity.

Allgenesis Biotherapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Memento Medicines
83%
MabTics Co., Ltd.
82%
INGENIA Therapeutics
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Allgenesis Biotherapeutics Inc. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Allgenesis Biotherapeutics Inc.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Madhu Cherukury

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Allgenesis Biotherapeutics Inc. Filings

Explore SEC and related filing metadata, where available.

Allgenesis Biotherapeutics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Allgenesis Biotherapeutics Inc.'s valuation, stock price, and market status.

Is Allgenesis Biotherapeutics Inc. a public or private company?

Allgenesis Biotherapeutics Inc. is a private company.

What is the current stock price of Allgenesis Biotherapeutics Inc.?

Allgenesis Biotherapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Allgenesis Biotherapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Allgenesis Biotherapeutics Inc. worth (valuation)?

Valuation information for Allgenesis Biotherapeutics Inc. is not publicly available.

Can I buy Allgenesis Biotherapeutics Inc. stock?

Allgenesis Biotherapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Allgenesis Biotherapeutics Inc.'s last funding round?

Funding round information for Allgenesis Biotherapeutics Inc. is not publicly available.

Who are the main investors in Allgenesis Biotherapeutics Inc.?

Investor information for Allgenesis Biotherapeutics Inc. is not publicly disclosed.

Will Allgenesis Biotherapeutics Inc. IPO soon?

No public IPO plans have been announced for Allgenesis Biotherapeutics Inc..

How can I track Allgenesis Biotherapeutics Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Allgenesis Biotherapeutics Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersTaipei
Employee Range4
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?